Regulations.gov document
NDI 805 - Pyrroloquinoline Quinone PQQ from Nascent Health Sciences LLC
Other · FDA-2013-S-0023 · posted Oct 31, 2014
Key facts
| Document ID | FDA-2013-S-0023-0114 |
|---|---|
| Title | NDI 805 - Pyrroloquinoline Quinone PQQ from Nascent Health Sciences LLC |
| Document type | Other |
| Subtype | 75 Day PreMarket Notification |
| Agency | FDA |
| Docket | FDA-2013-S-0023 |
| Posted | Oct 31, 2014 |
| Comment period opens | Oct 31, 2014 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: